Answers are grounded in this paper and cite their sources.
Shows enantiomer-dependent cytotoxicity in tumor cells, suggesting potential for targeted therapy.
Chiral Re(I) complexes are promising materials for optoelectronics and biomedicine, yet their potential remains largely untapped. Herein, we report a pair of enantiomeric Re(I) complexes, (+/−)‐[Re(CO) 3 (L)Br], supported by chiral dipino‐4,5‐diazafluorene‐based ligands (L). These complexes exhibit dual functionality in circularly polarized luminescence (CPL) and enantioselective cytotoxic activity. They display bright green CPL (phosphorescence) in both solution and the solid state, with | g lum | values of 10 −3 order. When employed as emitters in OLEDs, they achieve efficient green electroluminescence (λ EL = 530 nm). Moreover, these complexes readily enter tumor cells and display pronounced enantiomer‐dependent cytotoxicity. The (+)‐isomer shows higher toxicity toward Hep2 cells (LC 50 = 32.2 µ m ) than the (−)‐isomer (LC 50 > 50 µ m ), while the (−)‐isomer is twice as potent against SK‐LU‐1 cells (LC 50 = 12.6 µ m ) compared to its (+)‐analog. Strikingly, both enantiomers trigger profound cytoplasmic vacuolization–an unprecedented effect for Re(I) compounds. These data establish chiral Re(I) complexes as versatile candidates for advancing chiral photonics and targeted biomedical applications.
No takes yet. Share an insight, caveat, or question.
Davydova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: